S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
New CBOE “special perk” helps traders target income every weekend (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
New CBOE “special perk” helps traders target income every weekend (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
2 energy drink makers to wake up your portfolio
Snowflake’s bullish tailwind is turning into a gale-force wind
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
New CBOE “special perk” helps traders target income every weekend (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
New CBOE “special perk” helps traders target income every weekend (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
2 energy drink makers to wake up your portfolio
Snowflake’s bullish tailwind is turning into a gale-force wind
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
New CBOE “special perk” helps traders target income every weekend (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
New CBOE “special perk” helps traders target income every weekend (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
2 energy drink makers to wake up your portfolio
Snowflake’s bullish tailwind is turning into a gale-force wind
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
New CBOE “special perk” helps traders target income every weekend (Ad)
Why do tech stocks go down when interest rates rise?
Own Dollar General? Hurry and take this advice before earnings
New CBOE “special perk” helps traders target income every weekend (Ad)
Pure Storage stock fumbles for a rare buying opportunity
Black Swan: this small cap surged over 1000% last week
All the trading advice you’ve ever received boils down to this (Ad)
2 energy drink makers to wake up your portfolio
Snowflake’s bullish tailwind is turning into a gale-force wind

Hologic Stock Price, News & Analysis (NASDAQ:HOLX)

$70.58
-0.57 (-0.80%)
(As of 12/4/2023 ET)
Compare
Today's Range
$70.05
$71.30
50-Day Range
$65.11
$72.63
52-Week Range
$64.02
$87.88
Volume
2.00 million shs
Average Volume
1.66 million shs
Market Capitalization
$16.94 billion
P/E Ratio
38.57
Dividend Yield
N/A
Price Target
$86.58

Hologic MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.54 Rating Score
Upside/​Downside
22.7% Upside
$86.58 Price Target
Short Interest
Healthy
2.61% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.44
Upright™ Environmental Score
News Sentiment
0.89mentions of Hologic in the last 14 days
Based on 9 Articles This Week
Insider Trading
Selling Shares
$538,875 Sold Last Quarter
Proj. Earnings Growth
8.02%
From $3.99 to $4.31 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.99 out of 5 stars

Medical Sector

28th out of 952 stocks

X - Ray Apparatus & Tubes Industry

1st out of 6 stocks


HOLX stock logo

About Hologic Stock (NASDAQ:HOLX)

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalovirus; Aptima BV and Aptima CV/TV assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology, and treatment, such as 2D and 3D digital mammography systems, image analytics software, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and ultrasound and connectivity solutions, as well as breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology in the uterus; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; and the CoolSeal portfolio that includes bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HOLX Stock Price History

HOLX Stock News Headlines

30 Countries with the Lowest Median Age in the World
Hologic (NASDAQ:HOLX) Rating Lowered to Hold at StockNews.com
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Hologic, Inc. (NASDAQ:HOLX) Insider Sells $538,875.00 in Stock
Decoding Hologic Inc (HOLX): A Strategic SWOT Insight
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Hologic: Navigating The Covid Cliff
Q4 2023 Hologic Inc Earnings Call
Hologic fourth-quarter sales beat estimates
Hologic: Fiscal Q4 Earnings Snapshot
Hologic Inc Q4 Profit Decreases, but beats estimates
See More Headlines
Receive HOLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hologic and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
12/04/2023
Next Earnings (Estimated)
2/07/2024
Fiscal Year End
9/30/2024

Industry, Sector and Symbol

Industry
X - ray apparatus & tubes
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:HOLX
CUSIP
43644010
Employees
6,990
Year Founded
1985

Price Target and Rating

Average Stock Price Target
$86.58
High Stock Price Target
$105.00
Low Stock Price Target
$72.00
Potential Upside/Downside
+22.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.54
Research Coverage
13 Analysts

Profitability

Net Income
$456 million
Pretax Margin
16.77%

Debt

Sales & Book Value

Annual Sales
$4.03 billion
Cash Flow
$5.29 per share
Book Value
$20.48 per share

Miscellaneous

Free Float
236,019,000
Market Cap
$16.94 billion
Optionable
Optionable
Beta
1.01

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Should I Buy Hologic Stock? HOLX Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Hologic was last updated on Tuesday, November 28, 2023 at 10:40 PM.

Pros

Here are some ways that investors could benefit from investing in Hologic, Inc.:

  • Hologic, Inc. (NASDAQ:HOLX) beat earnings expectations in Q4 2023, with reported EPS of $0.89 compared to expectations of $0.85. This indicates strong financial performance and potential for future growth.
  • Hologic has a strong outlook for the fourth quarter of 2023, with positive projections for key metrics. This suggests that the company is well-positioned to perform well in the near future.
  • Recent developments and advancements in Hologic's products and technologies have the potential to drive revenue growth. Investors can benefit from the company's innovative solutions in the healthcare industry.
  • Hologic's stock price has shown positive momentum in recent periods, indicating investor confidence and potential for capital appreciation.
  • The company's strong presence in the market and its reputation for delivering high-quality products and services make it an attractive investment option.

Cons

Investors should be bearish about investing in Hologic, Inc. for these reasons:

  • Market volatility and uncertainties in the healthcare industry can impact Hologic's financial performance and stock price. Investors should carefully consider the risks associated with investing in this sector.
  • Competition in the healthcare industry is intense, and Hologic faces competition from both established players and emerging companies. This could affect the company's market share and profitability.
  • Regulatory changes and government policies related to healthcare can have a significant impact on Hologic's operations and financial results. Investors should stay informed about any potential regulatory risks.
  • Changes in consumer preferences and technological advancements in the healthcare sector could disrupt Hologic's business model and require significant investments in research and development.
  • Investors should carefully analyze Hologic's financial statements and performance metrics to assess the company's ability to generate consistent revenue and profitability in the long term.














HOLX Stock Analysis - Frequently Asked Questions

Should I buy or sell Hologic stock right now?

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Hologic in the last twelve months. There are currently 6 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" HOLX shares.
View HOLX analyst ratings
or view top-rated stocks.

What is Hologic's stock price target for 2024?

13 analysts have issued 1-year target prices for Hologic's shares. Their HOLX share price targets range from $72.00 to $105.00. On average, they anticipate the company's share price to reach $86.58 in the next year. This suggests a possible upside of 22.7% from the stock's current price.
View analysts price targets for HOLX
or view top-rated stocks among Wall Street analysts.

How have HOLX shares performed in 2023?

Hologic's stock was trading at $74.81 at the beginning of the year. Since then, HOLX shares have decreased by 5.7% and is now trading at $70.58.
View the best growth stocks for 2023 here
.

Are investors shorting Hologic?

Hologic saw a decline in short interest in November. As of November 15th, there was short interest totaling 6,180,000 shares, a decline of 13.4% from the October 31st total of 7,140,000 shares. Based on an average trading volume of 1,780,000 shares, the days-to-cover ratio is presently 3.5 days. Currently, 2.6% of the company's shares are sold short.
View Hologic's Short Interest
.

When is Hologic's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 7th 2024.
View our HOLX earnings forecast
.

How were Hologic's earnings last quarter?

Hologic, Inc. (NASDAQ:HOLX) announced its quarterly earnings data on Thursday, November, 9th. The medical equipment provider reported $0.89 EPS for the quarter, topping analysts' consensus estimates of $0.84 by $0.05. The medical equipment provider earned $945.30 million during the quarter, compared to the consensus estimate of $940 million. Hologic had a net margin of 11.31% and a trailing twelve-month return on equity of 19.12%. The company's revenue was down .8% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.82 EPS.
Read the conference call transcript
.

What guidance has Hologic issued on next quarter's earnings?

Hologic issued an update on its FY24 earnings guidance on Thursday, November, 9th. The company provided earnings per share (EPS) guidance of $3.90 to $4.10 for the period, compared to the consensus EPS estimate of $3.92. The company issued revenue guidance of $3.920 billion to $4.020 billion, compared to the consensus revenue estimate of $4.06 billion.

What is Steve MacMillan's approval rating as Hologic's CEO?

447 employees have rated Hologic Chief Executive Officer Steve MacMillan on Glassdoor.com. Steve MacMillan has an approval rating of 79% among the company's employees. 81.0% of employees surveyed would recommend working at Hologic to a friend.

What other stocks do shareholders of Hologic own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Hologic investors own include AbbVie (ABBV), NVIDIA (NVDA), Johnson & Johnson (JNJ), Alibaba Group (BABA), Walt Disney (DIS), PayPal (PYPL), Advanced Micro Devices (AMD), CVS Health (CVS), Pfizer (PFE) and Abbott Laboratories (ABT).

Who are Hologic's major shareholders?

Hologic's stock is owned by a variety of institutional and retail investors. Top institutional investors include Wellington Management Group LLP (2.41%), Victory Capital Management Inc. (1.98%), Parnassus Investments LLC (1.32%), Ameriprise Financial Inc. (1.28%), Northern Trust Corp (1.19%) and Invesco Ltd. (1.04%). Insiders that own company stock include Benjamin Jordan Cohn, Essex D Mitchell, Jan Verstreken, John M Griffin, Karleen Marie Oberton, Kevin R Thornal, Scott T Garrett, Sean S Daugherty and Sean S Daugherty.
View institutional ownership trends
.

How do I buy shares of Hologic?

Shares of HOLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Hologic have any subsidiaries?
The following companies are subsidiares of Hologic: Acessa Health, Acessa Health Inc., Beijing Hologic Technology Co. Ltd., Benassar Diagnostica-Equipamientos Medicos Unipessoal Lda., BioLucent, BioLucent LLC, Bioptics Inc., Biotheranostics Inc, Biotheranostics Inc., Bolder Surgical, Cynosure, Cytyc, Cytyc Corporation, Cytyc Prenatal Products Corp., Cytyc Surgical Products LLC, Diagenode Co. Ltd., Diagenode LLC, Diagenode SA, Diagenode SA., Diagenode SPA, Direct Radiography Corp., Emsor Sociedad de responsabilidad limitada, Faxitron Bioptics, Faxitron Bioptics LLC, Focal Therapeutics, Gen-Probe, Gen-Probe Incorporated, Gen-Probe Prodesse Inc., Gen-Probe Sales & Service Inc., Genewave SAS, Health Beacons Inc, Health Beacons Inc., Hologic (Australia & New Zealand) Pty Ltd., Hologic (MA) LLC, Hologic (Shanghai) Medical Supplies Co. Ltd., Hologic ASE LLC, Hologic Asia Limited, Hologic Asia Pacific Limited, Hologic Austria GmbH, Hologic BV, Hologic Bermuda Limited, Hologic Canada ULC, Hologic Caribbean (Barbados) SRL, Hologic Denmark ApS, Hologic Deutschland GmbH, Hologic Espana S.A., Hologic Finance Ltd., Hologic France SARL, Hologic GGO 2 LLC, Hologic GGO 3 LLP, Hologic GGO 4 LTD, Hologic Global Holding LTD, Hologic HUB LTD, Hologic Hitec-Imaging, Hologic Hitec-Imaging GmbH, Hologic Holdings Limited, Hologic IP LTD, Hologic Iberia S.L., Hologic India LLP, Hologic International Holdings B.V., Hologic Ireland Limited, Hologic Italia S.r.l., Hologic Japan KK, Hologic Latin America (Servicos Em Marketing E Negocios) Ltda., Hologic Ltd., Hologic Malaysia SDN. BHD., Hologic Medical Technologies (Beijing) Co. Ltd., Hologic Medicor GmbH, Hologic Medicor Suisse GmbH, Hologic Netherlands B.V., Hologic Nordic Holdings Oy, Hologic Singapore Pte. Ltd, Hologic Suisse SA, Hologic Surgical Products Costa Rica S.R.L., Hologic Sweden AB, Hologic Taiwan Ltd., Hologic UK Finance Ltd., Hologic US Finance Co LLC, Interlace Medical, Mobidiag Oy, Mobidiag Oy., Mobidiag UK Ltd., NXT-Dx SCRL, Navigation Three Limited, R2 Technology, Sentinelle Medical, Somatex (HK) Limited, Somatex Medical Technologies GmbH, Somatex Medical Technologies GmbH., Somatex USA Inc., SuperSonic Imagine (Shanghai) Medical Devices Co. Ltd., SuperSonic Imagine GmbH, SuperSonic Imagine HK Ltd, SuperSonic Imagine Ltd, SuperSonic Imagine SA, SuperSonic Imagine Srl, Suros Surgical Systems, Suros Surgical Systems Inc., TCT International, TCT International Co. Ltd., Third Wave Technologies, and Tridaho LLC.
Read More
This page (NASDAQ:HOLX) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -